期刊文献+

醛糖还原酶cDNA转染的CHO细胞株的建立及其基因表达与生化特性 被引量:3

The establishment of CHO cell line transfected with aldose reductase cDNA, its gene expression and biochemical characters
原文传递
导出
摘要 目的建立一内含人醛糖还原酶(hAR)cDNA的细胞株,并研究其在高葡萄糖环境中的基因表达及生化特性。方法将全长hARcDNA基因插入质粒载体pcDNAneo中,并将AR正义、反义构建以及pcDNAneo载体本身分别转染至中华仓鼠卵巢(CHO)细胞中。用放免法测定这些细胞株在高糖环境中的山梨醇水平。用Northern杂交检测其mRNA表达,并用分光光度法检测AR活性。结果有四株AR正义构建的细胞株显示了高山梨醇水平。随机将其中一株细胞作进一步分析,发现该细胞株具有ARmRNA表达,并且在高糖环境中AR活性亦显著升高。以上升高的山梨醇及酶活性均被AR抑制剂HOE843所抑制。结论本研究结果表明已成功地建立了一细胞系统,它为进一步研究AR在糖尿病并发症发病机理中的作用提供了手段。 Objective To create a cell line containing human aldose reductase (hAR) cDNA and to investigate its gene expression and biochemical characters under high glucose concentrations. Methods The full hAR cDNA was insert into the expression vector pcDNAneo. Cells from Chinese hamster ovary (CHO) were transfected with the AR sense construct, AR antisense construct and pcDNAneo vector alone. Sorbitol level was determined by RIA. AR mRNA expression was measured by Northern blots and AR activity was determined by using spectrophotometrical method. Results Four sense construct clones showed an elevated sorbitol production and one cell line was randomly chosen for further study. Northern analysis showed this cell line expressed hAR mRNA. Furthermore, this cell line had higher AR enzyme activity in response to raised glucose concentration. Increased sorbitol level and AR activity were significantly inhibited by an AR inhibitor HOE843. Conclusion We have established a cell line which would be an appropriate model to study the effect of AR on the pathogenesis of diabetic complication.
出处 《中华内分泌代谢杂志》 CAS CSCD 北大核心 1998年第6期380-382,共3页 Chinese Journal of Endocrinology and Metabolism
关键词 醛糖还原酶 糖尿病 并发症 基因转染 Aldose reductase Transfection Diabetic complication
  • 相关文献

同被引文献22

  • 1冯长根,张琳霞,刘霞.中草药来源的醛糖还原酶抑制剂的研究进展[J].中国中药杂志,2005,30(19):1496-1500. 被引量:25
  • 2刘慰华,杨冰,陶莎,王金平,郭芬芬,黄文革,陈凤英,刘培庆,黄河清.复方交泰丸对糖尿病大鼠肾损伤的保护作用及其机制的研究[J].中国药理学通报,2007,23(4):559-560. 被引量:15
  • 3kKinekawa F, Kubo F, Matsuda K,et al. Effect of an aldosc reductase inhibitor on esophageal dysfunction in diabetic patients [ J ]. Hepatogastroenterology, 2005,52(62 ) :471 -4.
  • 4Oates P J. Aldose reductase, still a compelling target for diabetic neuropathy [ J ]. Curt Drug Targets, 2008, 9 ( 1 ) : 14 - 36.
  • 5Srivastava S K, Ansari N H, Hair G A, et al. Aldose and aide - hyde reductase in human tissue[ J]. Biochim Biophys Acta, 1984, 800(3) :220 -7.
  • 6Yang S Q. Chinese Medical Encyclopedia--medical statistics [ M ]. Shanghai: Shanghai Science and Technology Publishing House, 1985 : 197 - 202.
  • 7Mylari B L, Larson E R, Beyer T A, et al. Novel, potent aldose reductase inhibitors : 3,4-dihydro-4-oxo-3- { [ 5-( trifluoromethyl ) - 2-benzothiazolyl] methyl}-1-phthalazineacetic acid (zopolrestat) and congeners[ J]. J Med Chem, 1991,34( 1 ) : 108 - 22.
  • 8Zenon GJ,Abobo CV,Carter BL,et al.Potential use of aldose reductase inhibitors to prevent diabetic complications[J].Clin Pharm,1990;9:446.
  • 9Bokman SH,Ward WW.Renaturation of aequorea green-fluorsescent protein[J].Biochem Biophys Res Commun,1981;101:1372.
  • 10Ward WW,Bokman SH.Reversible denaturation of Aequorea green-fluorsescent protein:physical separation and characterization of the renatured protein[J].Biochemistry,1982;21:4535.

引证文献3

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部